Oncologic Outcomes of Template Versus Radioguided Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography Scan: Results ...

UroToday's exclusive Video Lecture content covering Bladder Cancer.

SCU 2025, Prostate Cancer, Evaluation and Management of Biochemical Recurrence in Prostate Cancer, POUND study, RADICALS-RT study, GETUG-AFU 17 study, RAVES study, External Beam Radiation Therapy ...

PSMA and Beyond 2025 PSMAfore trial, SPLASH trial, ECLIPSE trial, PSMA radioligand therapy, PSMAfore compared to SPLASH, SPLASH LuPSMA arm, PSMAfore LuPSMA arm, ProstACT GLOBAL.

PSMA and Beyond 2025 antibody drug development (ADC) in prostate cancer, ADC program in advance prostate cancer, PSMA expression, ...

(UroToday.com) The 2025 European Association of Urology (EAU) Annual Congress held in Madrid, Spain between March 21 st and 24 th 2025, was host to a thematic session on intravesical therapy for ...

Final overall survival and safety analyses of the phase 3 PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic ...

(UroToday.com) The 2025 European Association of Urology (EAU) Annual Congress held in Madrid, Spain, between March 21 st and 24 th 2025, was host to a thematic session on hot topics in the management ...